Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
from Benchmark Co. issued a price target of $33.00 for INBK on 2026-06-24 20:37:00.The adjusted price target was set to $33.00.At the time of the announcement, INBK...
June 24, 2026 INBK 1.08%
Max Masucci from Roth Capital issued a price target of $32.00 for BDSX on 2026-06-24 20:26:28.The adjusted price target was set to $32.00.At the time of the announcement,
June 24, 2026 BDSX -2.56%
Leonid Timashev from RBC Capital issued a price target of $15.00 for VSTM on 2026-06-24 13:37:00.The adjusted price target was set to $15.00.At the time of the announcement,
June 24, 2026 VSTM -8.55%
Keith Tapper from Pivotal Research issued a price target of $14.00 for TSHA on 2026-06-23 13:16:57.The adjusted price target was set to $14.00.At the time of the announcement,
June 23, 2026 TSHA 1.17%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| ICCM IceCure Medical Ltd | 9.30
51.96% | ||||||||||||||||||
| SCLXW SCLXW | 0.19
37.79% | ||||||||||||||||||
| ABSI Absci Corporation | 10.07
35.90% | ||||||||||||||||||
| GALT Galectin Therapeutics Inc | 3.92
25.64% | ||||||||||||||||||
| LIFE Ethos Technologies Inc. | 18.10
18.61% | ||||||||||||||||||
| BDTX Black Diamond Therapeutic | 1.86
15.53% | ||||||||||||||||||
| PSNL Personalis, Inc. | 11.36
12.92% | ||||||||||||||||||
| BNR Burning Rock Biotech Limi | 8.52
12.70% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -0.46%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -6.63%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -2.31%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 0.51%